These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

323 related items for PubMed ID: 18848893

  • 1. Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.
    Rodrigues LG, Ferraz MJ, Rodrigues D, Pais-Vieira M, Lima D, Brady RO, Sousa MM, Sá-Miranda MC.
    Neurobiol Dis; 2009 Jan; 33(1):48-56. PubMed ID: 18848893
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. An in vitro model of Fabry disease.
    Shu L, Murphy HS, Cooling L, Shayman JA.
    J Am Soc Nephrol; 2005 Sep; 16(9):2636-45. PubMed ID: 16033856
    [Abstract] [Full Text] [Related]

  • 4. Functional and structural nerve fiber findings in heterozygote patients with Fabry disease.
    Torvin Møller A, Winther Bach F, Feldt-Rasmussen U, Rasmussen A, Hasholt L, Lan H, Sommer C, Kølvraa S, Ballegaard M, Staehelin Jensen T.
    Pain; 2009 Sep; 145(1-2):237-45. PubMed ID: 19665302
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Long-term systemic therapy of Fabry disease in a knockout mouse by adeno-associated virus-mediated muscle-directed gene transfer.
    Takahashi H, Hirai Y, Migita M, Seino Y, Fukuda Y, Sakuraba H, Kase R, Kobayashi T, Hashimoto Y, Shimada T.
    Proc Natl Acad Sci U S A; 2002 Oct 15; 99(21):13777-82. PubMed ID: 12370426
    [Abstract] [Full Text] [Related]

  • 7. Alpha-galactosidase A in vascular disease.
    Bodary PF, Shayman JA, Eitzman DT.
    Trends Cardiovasc Med; 2007 May 15; 17(4):129-33. PubMed ID: 17482095
    [Abstract] [Full Text] [Related]

  • 8. Fabry disease.
    Schiffmann R.
    Pharmacol Ther; 2009 Apr 15; 122(1):65-77. PubMed ID: 19318041
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
    Sueoka H, Aoki M, Tsukimura T, Togawa T, Sakuraba H.
    PLoS One; 2015 Apr 15; 10(12):e0144958. PubMed ID: 26661087
    [Abstract] [Full Text] [Related]

  • 15. [Fabry disease].
    Jakubowska E, Ryba M, Hruby Z.
    Przegl Lek; 2006 Apr 15; 63(4):218-9. PubMed ID: 17080745
    [Abstract] [Full Text] [Related]

  • 16. Efficient correction of Fabry mice and patient cells mediated by lentiviral transduction of hematopoietic stem/progenitor cells.
    Yoshimitsu M, Higuchi K, Ramsubir S, Nonaka T, Rasaiah VI, Siatskas C, Liang SB, Murray GJ, Brady RO, Medin JA.
    Gene Ther; 2007 Feb 15; 14(3):256-65. PubMed ID: 16929352
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Altered globotriaosylceramide accumulation and mucosal neuronal fiber density in the colon of the Fabry disease mouse model.
    Masotti M, Delprete C, Dothel G, Donadio V, Rimondini R, Politei JM, Liguori R, Caprini M.
    Neurogastroenterol Motil; 2019 Mar 15; 31(3):e13529. PubMed ID: 30609268
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.